首页>
外国专利>
Application of Kelimycin in anti-tuberculosis infection
Application of Kelimycin in anti-tuberculosis infection
展开▼
机译:凯利霉素在抗结核感染中的应用
展开▼
页面导航
摘要
著录项
相似文献
摘要
Use of carrimycin in mycobacterium tuberculosis infection resistance comprises the main steps: measuring the activity of carrimycin in mycobacterium tuberculosis resistance by adopting an absolute concentration method through taking clinical first-line antituberculotics, i.e., isoniazid and rifampicin as controls. The result indicates that carrimycin has obvious superior activity to clinically-separated mycobacterium tuberculosis including drug-resistant bacteria compared with those of the clinical first-line control drugs, i.e., the isoniazid and the rifampicin, and use of carrimycin in manufacturing drugs for treating tubercle bacillus infected diseases are expected to be developed.
展开▼